IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dcvc Opportunity Fund II GP, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 2 holdings | $13.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$12.1M3,951,14187.5%
IonQ, Inc.(IONQ)CL A46222L108$1.7M60,22612.5%